BOKF vs PACS
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
BOKF · BOK Financial$129.48 ▼ 0.42%
PACS · PACS Group$49.60 ▼ 1.20%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- BOKF +21.7%
- PACS +296.8%
Head to head
| Metric | BOKF | PACS |
|---|---|---|
| Price | $129.48 | $49.60 |
| Change today | ▼ 0.42% | ▼ 1.20% |
| Market cap | $7.87B | $7.87B |
| Return, 3 months | -9.2% | +2.4% |
| Return, year to date | +10.8% | +29.2% |
| Return, 1 year | +22.2% | +302.6% |
| P/E (TTM) | 11.7 | 28.2 |
| P/B | 1.3 | 6.5 |
| P/E percentile vs own 5y | 43rd | 58th |
| Dividend yield | 1.95% | – |
| Revenue growth (YoY, latest qtr) | +2.4% | +9.1% |
| Net profit growth (YoY) | +13.5% | +49.8% |
| Gross margin | – | 16.6% |
| Operating margin | – | 7.4% |
| Net margin | 30.4% | 4.8% |
| Return on equity | 11.2% | 28.1% |
| Analyst target vs. price | +11.8% | +16.9% |
| Analyst buy share | 0% | 100% |
| RSI (14) | 50 | 60 |
| 30-day volatility | 20.7% | 44.4% |
| Max drawdown, 1 year | -15.5% | -27.9% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- PACS is the largest of the group by market value.
- PACS has returned the most over the past year.
- BOKF carries the lowest trailing P/E.
- PACS is growing revenue fastest.
- BOKF keeps the most profit per dollar of sales.
- BOKF has been the calmest stock over the last 30 days.